Table of Contents

Step therapy is a common practice in many health insurance plans. It is the most frequently used restriction for specialty drug coverage. A 2021 study found that step therapy was included in about 39% of drug policies, with nearly half of these policies being stricter than national clinical guidelines.

For medications like Mounjaro (tirzepatide), which is approved for type 2 diabetes and shows potential for weight management, step therapy can impact how quickly you can access treatment.

In this article, we will discuss what step therapy for Mounjaro is, how to handle it, and the reasons behind its use.

Key Takeaways

  • Metformin is commonly required as the first treatment for type 2 diabetes due to its effectiveness, safety, and affordability.
  • Depending on your insurance, you might need to try other GLP-1 receptor agonists like Ozempic or Trulicity first and prove they didn’t work for you before getting approval for Mounjaro.
  • You can request a step therapy exception if required treatments don’t work for you, cause harm, or aren’t in your best interest medically.
  • In certain states, your insurer must respond to exception requests within a set timeframe, but in others, you could face delays without clear deadlines.
  • If your exception request is denied, you can appeal in many states, though some don’t offer this option, which can complicate the process.
  • To handle step therapy, know your insurance plan, document treatments that didn’t work, prepare appeals, and look into state-specific protections or different insurance plans.

What is Step Therapy?

Step therapy, often called a “fail-first” approach, is a policy used by insurance providers to manage costs and encourage the use of established treatments.

Under this approach, your insurance might require you to try more affordable, first-line medications before covering more expensive or advanced options. The goal is to ensure effective treatments are used while keeping healthcare affordable.

For managing type 2 diabetes, metformin is the standard first-line treatment. It’s widely regarded as safe, well-tolerated, and effective for achieving long-term health outcomes. Additionally, metformin is moderately priced and features a straightforward dosing regimen, making it a practical choice for many patients.

Mounjaro Pen - Mounjaro Step Therapy

What is Step Therapy for Mounjaro?

Each insurance plan has its own step therapy policies for Mounjaro. For example:

If You Have Aetna

Aetna requires you to try certain preferred medications, like Ozempic (semaglutide) or Trulicity (dulaglutide), before they will consider covering Mounjaro. To qualify for approval, you must meet one of the following conditions:

    • You didn’t get the desired results from these medications
    • You experienced side effects or intolerance
    • You have a medical condition that prevents you from using them (contraindication)

Additional requirements may include:

    • If you’ve been on Mounjaro for less than three months, Aetna may require proof that metformin didn’t work for you or that you need combination therapy with an A1C of 7.5% or higher.
    • If you’ve been on Mounjaro for more than three months, you’ll need to show improvement in your A1C levels to continue coverage.

Coverage is typically approved for 12 months at a time. You may also face a quantity limit of four single-dose pens or vials every 28 days.

Switching from Ozempic to Mounjaro?

If Aetna’s step therapy policy has you wondering about the transition from Ozempic to Mounjaro, we’ve got you covered! Learn everything you need to know about making the switch, including benefits, differences, and tips for a smooth transition.

If CVS Caremark Manages Your Prescription Benefits

They may require you to try metformin first before approving Mounjaro. Their process typically involves checking whether you’ve filled at least a 30-day supply of metformin in the last six months under your prescription benefits.

If you haven’t tried metformin, your initial request for Mounjaro may be denied, and you’ll receive a notification that prior authorization (PA) is required.

You or your doctor will need to submit a prior authorization request, including a detailed explanation of why you need Mounjaro. CVS Caremark will review your case based on their criteria for medical necessity.

Step therapy protocols differ not only among insurance providers but also across states. To ensure accurate information and avoid delays, the best approach is to contact your insurance provider directly for details on their specific requirements and approval process.

Real-World Experiences with Mounjaro’s Step Therapy Policy

A Reddit discussion highlighted confusion over step therapy requirements for Mounjaro and similar medications. The original poster (OP) was concerned about insurance changes requiring patients to try metformin first, unsure if this applied to them as an existing Mounjaro user.

One user encouraged OP to call their insurer, sharing how a representative clarified their own policy and even suggested manufacturer coupons. OP later updated that their doctor confirmed they likely weren’t a “new start,” but they planned to increase their dosage to see if it triggered the rule. They humorously described this as “playing health roulette every month.”

Other commenters offered practical advice. One commenter shared a tip, explaining that filling a 90-day metformin prescription was enough, even without actually using the medication.

Another commenter raised an important question about proving prior use of metformin, especially if it had been prescribed years ago under a different insurance plan.

In the end, OP took proactive steps and scheduled a follow-up with their doctor to avoid disrupting the 42 lbs they’d lost on Mounjaro.

Exceptions to Step Therapy

A Step Therapy Exception is a process that lets patients skip the standard step therapy requirements imposed by their insurer in certain situations. This ensures you can access the medications you truly need, even if typical insurance rules would limit coverage.

It’s designed to prevent delays in your treatment, especially when a specific medication is critical to managing your condition.

How to Qualify for a Step Therapy Exception

You might be eligible for an exception if any of the following apply:

    • You’ve already tried the required drug, and it didn’t work for you.
    • The drug has been ineffective in the past.
    • The drug is expected to be ineffective based on your condition.
    • The drug is likely to cause harm or severe side effects.
    • The drug isn’t in your best interest from a medical perspective.
    • You’re responding well to your current medication.
    • The drug is contraindicated for your condition.

How to Apply for a Step Therapy Exception

The criteria and the process can differ depending on where you live. While federal guidelines set some standards, states often have their own rules. For example, in Oklahoma, under the SoonerCare Medicaid program, the process involves:

    • Your healthcare provider submits an exception request form, along with supporting documentation, to explain why the required step therapy drug isn’t appropriate for you (e.g., contraindications, adverse reactions, or ineffectiveness).
    • Approval is typically granted if the documentation shows the required drug is contraindicated, likely to cause harm, expected to be ineffective, or if you’re stable on your current medication.

Once the request is reviewed, the Oklahoma Health Care Authority (OHCA) may:

    • Approve the exception
    • Deny the request, citing medical necessity
    • Request additional information if documentation is missing or incomplete
    • Notify you if you’re no longer eligible for coverage
    • Inform you if the request can’t be processed due to submission errors

If you think you qualify for an exception, talk to your provider. They’ll know how to guide you through the process.

US State Regulations on Step Therapy Exception

Currently, 29 states have laws in place requiring insurers to provide a Step Therapy Exception when it is medically necessary.

According to an audit published by Cambridge University Press, the strength of these laws varies widely. The weakest step therapy laws are found in California, Oregon, and Missouri. In contrast, Ohio stands out as having the strongest law.

Below is a table outlining the primary reasons accepted in each of these states:

State Patient has tried and failed on required drug Required drug has been ineffective in past Required drug is expected to be ineffective Required drug will likely cause adverse reaction or harm Required drug is not in best interest of patient Patient is responding positively to current drug regimen Required drug is contraindicated
Arkansas
California
Colorado
Connecticut
Delaware
Georgia
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Minnesota
Mississippi
Missouri
New Mexico
New York
North Carolina
Ohio
Oklahoma
Oregon
South Dakota
Texas
Virginia
Washington
West Virginia
Wisconsin
Data Source: Cambridge University Press

Timeline for Approval

In some states, if an insurer doesn’t respond to a Step Therapy Exception request within a specific time frame, the request is automatically approved. This ensures patients aren’t stuck waiting indefinitely for coverage decisions.

For Urgent Cases For Non-Urgent Cases Applicable States
72 hours 5 calendar days Iowa, Minnesota, South Dakota
72 hours 72 hours Arkansas, Kansas
1 business day 3 business days Indiana, Washington
24 hours 72 hours California, Illinois, Louisiana, Maine, New Mexico, New York, North Carolina
48 hours 10 calendar days Ohio
24 hours 48 hours Oklahoma, Texas, Virginia
24 hours 2 business days Delaware, Georgia

Unfortunately, this is not the case in every state. In some states, insurers are not legally required to respond within a specific timeframe, which can lead to indefinite delays in patients accessing the medications they need. These states include:

    1. Colorado
    2. Connecticut
    3. Kentucky
    4. Maryland
    5. Mississippi
    6. Missouri
    7. Oregon
    8. Wisconsin
    9. West Virginia

Regulations on Appeal Process

If your request is denied, you can appeal the decision. However, some states have no appeal process for denied Step Therapy Exception requests. This, unfortunately, leaves patients with no way to challenge an insurer’s decision. These states include:

    1. California
    2. Colorado
    3. Kansas
    4. Kentucky
    5. Maryland
    6. Mississippi
    7. Missouri
    8. Oklahoma
    9. Oregon
    10. West Virginia

It’s worth noting that these laws might have changed or been updated since their publication, so it’s always a good idea to verify the current regulations with your state. Work closely with your healthcare and insurance provider to ensure your needs are met.

Tips for Patients Facing Step Therapy for Mounjaro

To successfully handle step therapy requirements for Mounjaro, you can take these steps:

    • Study your plan’s policy: Inquire about your insurance’s specific requirements for step therapy and note any exemptions for conditions like diabetes.
    • Prepare for alternatives: Discuss the required medications with your doctor and plan for how to document their effects if you need to try them first.
    • Show medical urgency: Ask your doctor to highlight why delaying Mounjaro could negatively impact your health, especially if you’ve struggled with alternatives before.
    • Create a compelling appeal: Include personal notes about past experiences with ineffective treatments to strengthen your case.
    • Ask for fast-tracking: If step therapy delays treatment, inquire about expedited appeal processes allowed for urgent cases.
    • Track everything: Keep a detailed log of insurer communications, medication responses, and appeal deadlines to stay organized.
    • Look for legal protections: Research state-specific laws that might override step therapy mandates for immediate access to medications.
    • Reach out for support: Join online diabetes communities or forums where others share tips and successful step therapy strategies.
    • Plan long-term: If step therapy becomes a recurring issue, review other insurance options with fewer barriers during open enrollment.

Takeaway

Step therapy can be frustrating when trying to access medications like Mounjaro. To get through this process, it helps to know your insurance plan’s rules, keep track of any treatments that didn’t work, and work with your doctor to request an exception if needed.

State laws can also impact your options, with some requiring insurers to respond quickly to exception requests or allow appeals for denials. Knowing these protections and staying organized can help you overcome delays. By being proactive and persistent, you can secure the medication that works best for your health.

Lower Your Mounjaro Costs with Pharma Giant!

Don’t let denied insurance coverage stop you from accessing Mounjaro! At Pharma Giant, prices start at just $158.99, and we offer Mounjaro coupons to help you save even more.

Order Mounjaro today!

Frequently Asked Questions

The timeline varies, ranging from a few days to weeks, depending on the insurance company’s response and appeal process.
A healthcare provider can document the adverse effects and request an exception to step therapy for Mounjaro.
Pharmacists can provide valuable support by explaining insurance requirements and assisting with documentation for prior authorization or appeals.
Yes, insurance plans often update their policies yearly, which can include changes to step therapy requirements.
Manufacturer savings programs or patient assistance programs may offer options to reduce out-of-pocket costs without step therapy.
Yes, even after step therapy, insurers may require additional prior authorizations or may still deny coverage based on other criteria.
While insurance companies generally do not charge for appeals, there could be indirect costs, such as doctor visits or additional tests.

Sources

Lenahan, K. L., Nichols, D. E., Gertler, R. M., & Chambers, J. D. (2021). Variation In Use And Content Of Prescription Drug Step Therapy Protocols, Within And Across Health Plans. Health affairs (Project Hope), 40(11), 1749–1757. https://doi.org/10.1377/hlthaff.2021.00822

Steinberg, J., & Carlson, L. (2019). Type 2 Diabetes Therapies: A STEPS Approach. American family physician, 99(4), 237–243. PubMed. https://pubmed.ncbi.nlm.nih.gov/30763055/

Tharp, L., & Rothblatt, Z. (2021). Do patients benefit from legislation regulating step therapy? Health Economics Policy and Law, 17(3), 282–297. https://doi.org/10.1017/s1744133121000153

AETNA BETTER HEALTH. (2024). Coverage Policy/Guideline for Mounjaro. Retrieved from https://www.aetnabetterhealth.com/content/dam/aetna/medicaid/pdfs/formulary/guidelines/Mounjaro-Aetna-Medicaid-Policy-ua.pdf

CVS Caremark. (2023). STEP THERAPY CRITERIA FOR ANTIDIABETIC AGENTS. Retrieved from https://www.nhpri.org/wp-content/uploads/2023/03/Antidiabetic-Agents-ST-Post-PA-Policy-676-D-08-2022-v2.pdf